We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Biosensing Technology Breakthrough Paves Way for New Methods of Early Disease Detection

By LabMedica International staff writers
Posted on 11 Dec 2024

Nanopores are tiny openings that can detect individual molecules as they pass through, making them ideal for analyzing biomolecules like DNA and proteins. More...

However, detecting proteins at extremely low concentrations—such as those found in the early stages of diseases—has been challenging. Now, a new breakthrough in nanotechnology for biomolecule detection and analysis could open doors to more effective early disease detection methods.

In a study conducted at SMU Lyle (Dallas, TX, USA) and featured on the cover of Analytical Chemistry, researchers combined octahedral DNA origami structures with solid-state nanopores to enhance the detection of proteins, particularly those present in low concentrations. The researchers found that integrating DNA origami's precision with the strength of solid-state nanopores results in a "hybrid nanopore" system, offering more accurate and sensitive protein detection. DNA origami is a technique in which DNA strands are folded into specific shapes, such as an octahedron, to improve the nanopore’s capacity to capture and detect proteins. In their study, the researchers used holo human serum transferrin as a model protein, demonstrating that this hybrid nanopore system outperformed traditional nanopores in both sensitivity and detection accuracy.

Many diseases, including cancer and neurodegenerative disorders, are marked by proteins present in very small quantities, making them difficult to detect in the early stages. The hybrid nanopore's ability to detect these low-abundance proteins could lead to earlier diagnoses and more effective treatment outcomes. Moving forward, the research team plans to refine the DNA origami structure and nanopore configurations to further improve sensitivity and expand the range of detectable biomolecules. This innovative approach could revolutionize fields like drug discovery, disease diagnostics, and fundamental biological research.

“This work could pave the way for developing advanced biosensing technologies, with potential applications in biomedical research and diagnostic tools – especially for diseases marked by low-abundance protein biomarkers,” said SMU Lyle mechanical engineering graduate student Kamruzzaman Joty.


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Nutating Mixer
Enduro MiniMix
New
Epstein-Barr Virus Test
Mononucleosis Rapid Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.